HP
38
-2
SO
55
-2
PPL
54
2
MS
74
-2
TAP
58
-2
MUR
43
3
VTR
49
-3
CSX
51
-2
DNB
78
6
CMCSA
48
2
AXP
66
2
VLO
40
-2
PNW
66
3
FLS
73
-2
HAS
30
2
ZBH
60
-2
MRO
55
3
SRE
63
-3
GM
65
-3
GRMN
62
-3
HP
38
-2
SO
55
-2
PPL
54
2
MS
74
-2
TAP
58
-2
MUR
43
3
VTR
49
-3
CSX
51
-2
DNB
78
6
CMCSA
48
2
AXP
66
2
VLO
40
-2
PNW
66
3
FLS
73
-2
HAS
30
2
ZBH
60
-2
MRO
55
3
SRE
63
-3
GM
65
-3
GRMN
62
-3
Financhill
Back

Aligos Therapeutics Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Buy
55

ALGS
Aligos Therapeutics

Last Price:
17.80
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Aligos Therapeutics Price Quote

$17.80
-0.40 (-2.2%)
(Updated: November 21, 2024 at 9:50 AM ET)

Aligos Therapeutics Key Stats

Buy
55
Aligos Therapeutics (ALGS) is a Buy
Day range:
$17.88 - $19.85
52-week range:
$6.76 - $30.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.28
P/B ratio:
1.44%
Volume:
471.8K
Avg. volume:
407.3K
1-year change:
1.42%
Market cap:
$72.2M
Revenue:
$15.5M
EPS:
$-17.11

How Much Does Aligos Therapeutics Make?

Is Aligos Therapeutics Growing As A Company?

  • What Is Aligos Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.61%
  • What Is Aligos Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Aligos Therapeutics Stock Price Performance

What Is Aligos Therapeutics 52-Week High & Low?

Aligos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aligos Therapeutics?

Is Aligos Therapeutics Cash Flow Positive?

  • What Is ALGS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$85M
  • What Is Aligos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $88.2M
  • What Is Aligos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$38.3M

Aligos Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    ALGS return on invested capital is -118.75%
  • What Is Aligos Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -68.4%
  • What Is ALGS Return On Equity?
    ROE is a measure of profitability and is -118.75%

Aligos Therapeutics Earnings Date & Stock Price

Aligos Therapeutics Competitors

Aligos Therapeutics Dividend Yield

Aligos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -131.7%
Revenue: -60.82% 280.7%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 103.33
Upside from Last Price: 467.77%

Major Shareholders

  • How many ALGS shares are owned by institutional investors?
    43.8M ALGS shares are owned by institutional investors
  • How many ALGS shares are owned by insiders?
    0 ALGS shares are owned by insiders